SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-010281
Filing Date
2024-03-11
Accepted
2024-03-11 17:20:25
Documents
1
Period of Report
2024-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1710192010.html 4  
1 FORM 4 wk-form4_1710192010.xml 4 3901
  Complete submission text file 0001628280-24-010281.txt   5497
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET, 4TH FLOOR BOSTON MA 02134
Business Address
Taveras Arthur (Reporting) CIK: 0001830901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 24739169